Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Insomnia Treatment Drugs Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Insomnia Treatment Drugs Market Status and Forecast (2016-2027)
      • 1.3.2 Global Insomnia Treatment Drugs Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Insomnia Treatment Drugs Supply by Company

    • 2.1 Global Insomnia Treatment Drugs Sales Volume by Company
    • 2.2 Global Insomnia Treatment Drugs Sales Value by Company
    • 2.3 Global Insomnia Treatment Drugs Price by Company
    • 2.4 Insomnia Treatment Drugs Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Insomnia Treatment Drugs Market Status by Category

    • 3.1 Insomnia Treatment Drugs Category Introduction
      • 3.1.1 Prescription Sleep Aids
      • 3.1.2 Over the Counter (OTC) Sleep Aids
    • 3.2 Global Insomnia Treatment Drugs Market by Category
      • 3.2.1 Global Insomnia Treatment Drugs Sales Volume by Category (2016-2021)
      • 3.2.2 Global Insomnia Treatment Drugs Sales Value by Category (2016-2021)
      • 3.2.3 Global Insomnia Treatment Drugs Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Insomnia Treatment Drugs Market Status by End User/Segment

    • 4.1 Insomnia Treatment Drugs Segment by End User/Segment
      • 4.1.1 Hospital
      • 4.1.2 Pharmacy
      • 4.1.3 Others
    • 4.2 Global Insomnia Treatment Drugs Market by End User/Segment
      • 4.2.1 Global Insomnia Treatment Drugs Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Insomnia Treatment Drugs Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Insomnia Treatment Drugs Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Insomnia Treatment Drugs Market Status by Region

    • 5.1 Global Insomnia Treatment Drugs Market by Region
      • 5.1.1 Global Insomnia Treatment Drugs Sales Volume by Region
      • 5.1.2 Global Insomnia Treatment Drugs Sales Value by Region
    • 5.2 North America Insomnia Treatment Drugs Market Status
    • 5.3 Europe Insomnia Treatment Drugs Market Status
    • 5.4 Asia Pacific Insomnia Treatment Drugs Market Status
    • 5.5 Central & South America Insomnia Treatment Drugs Market Status
    • 5.6 Middle East & Africa Insomnia Treatment Drugs Market Status

    6 North America Insomnia Treatment Drugs Market Status

    • 6.1 North America Insomnia Treatment Drugs Market by Country
      • 6.1.1 North America Insomnia Treatment Drugs Sales Volume by Country (2016-2021)
      • 6.1.2 North America Insomnia Treatment Drugs Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Insomnia Treatment Drugs Market Status

    • 7.1 Europe Insomnia Treatment Drugs Market by Country
      • 7.1.1 Europe Insomnia Treatment Drugs Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Insomnia Treatment Drugs Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Insomnia Treatment Drugs Market Status

    • 8.1 Asia Pacific Insomnia Treatment Drugs Market by Country
      • 8.1.1 Asia Pacific Insomnia Treatment Drugs Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Insomnia Treatment Drugs Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Insomnia Treatment Drugs Market Status

    • 9.1 Central & South America Insomnia Treatment Drugs Market by Country
      • 9.1.1 Central & South America Insomnia Treatment Drugs Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Insomnia Treatment Drugs Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Insomnia Treatment Drugs Market Status

    • 10.1 Middle East & Africa Insomnia Treatment Drugs Market by Country
      • 10.1.1 Middle East & Africa Insomnia Treatment Drugs Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Insomnia Treatment Drugs Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Insomnia Treatment Drugs Manufacturing Cost Analysis
    • 11.5 Insomnia Treatment Drugs Sales Channel and Distributors Analysis
      • 11.5.1 Insomnia Treatment Drugs Sales Channel
      • 11.5.2 Insomnia Treatment Drugs Distributors
    • 11.6 Insomnia Treatment Drugs Downstream Major Buyers

    12 Global Insomnia Treatment Drugs Market Forecast by Category and by End User/Segment

    • 12.1 Global Insomnia Treatment Drugs Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Insomnia Treatment Drugs Forecast by Category
      • 12.2.1 Global Insomnia Treatment Drugs Sales Volume Forecast by Category
      • 12.2.2 Global Insomnia Treatment Drugs Sales Value Forecast by Category
      • 12.2.3 Global Insomnia Treatment Drugs Price Forecast by Category
    • 12.3 Global Insomnia Treatment Drugs Forecast by End User/Segment
      • 12.3.1 Global Insomnia Treatment Drugs Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Insomnia Treatment Drugs Sales Value Forecast by End User/Segment
      • 12.3.3 Global Insomnia Treatment Drugs Price Forecast by End User/Segment

    13 Global Insomnia Treatment Drugs Market Forecast by Region/Country

    • 13.1 Global Insomnia Treatment Drugs Market Forecast by Region (2022-2027)
      • 13.1.1 Global Insomnia Treatment Drugs Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Insomnia Treatment Drugs Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Vanda Pharmaceuticals, Inc.
      • 14.1.1 Company Information
      • 14.1.2 Insomnia Treatment Drugs Product Introduction
      • 14.1.3 Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Teva Pharmaceutical Industries Ltd.
      • 14.2.1 Company Information
      • 14.2.2 Insomnia Treatment Drugs Product Introduction
      • 14.2.3 Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Takeda Pharmaceutical Company Ltd.
      • 14.3.1 Company Information
      • 14.3.2 Insomnia Treatment Drugs Product Introduction
      • 14.3.3 Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Sumitomo Dainippon Pharma Co., Ltd
      • 14.4.1 Company Information
      • 14.4.2 Insomnia Treatment Drugs Product Introduction
      • 14.4.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Sanofi S.A.
      • 14.5.1 Company Information
      • 14.5.2 Insomnia Treatment Drugs Product Introduction
      • 14.5.3 Sanofi S.A. Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Pfizer, Inc.
      • 14.6.1 Company Information
      • 14.6.2 Insomnia Treatment Drugs Product Introduction
      • 14.6.3 Pfizer, Inc. Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Pernix Therapeutics
      • 14.7.1 Company Information
      • 14.7.2 Insomnia Treatment Drugs Product Introduction
      • 14.7.3 Pernix Therapeutics Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Mylan N.V.
      • 14.8.1 Company Information
      • 14.8.2 Insomnia Treatment Drugs Product Introduction
      • 14.8.3 Mylan N.V. Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Merck & Co. Inc.
      • 14.9.1 Company Information
      • 14.9.2 Insomnia Treatment Drugs Product Introduction
      • 14.9.3 Merck & Co. Inc. Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 F.Hoffman La-Roche AG
      • 14.10.1 Company Information
      • 14.10.2 Insomnia Treatment Drugs Product Introduction
      • 14.10.3 F.Hoffman La-Roche AG Insomnia Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Insomnia Treatment Drugs market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Insomnia Treatment Drugs market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Prescription Sleep Aids
      Over the Counter (OTC) Sleep Aids

      Segmented by End User/Segment
      Hospital
      Pharmacy
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Vanda Pharmaceuticals, Inc.
      Teva Pharmaceutical Industries Ltd.
      Takeda Pharmaceutical Company Ltd.
      Sumitomo Dainippon Pharma Co., Ltd
      Sanofi S.A.
      Pfizer, Inc.
      Pernix Therapeutics
      Mylan N.V.
      Merck & Co. Inc.
      F.Hoffman La-Roche AG
      Buy now